A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a broad range of innovative products to improve human health. As an organization, our core values are driven by a desire to improve human life, achieve scientific excellence, operate with the highest standards of integrity, expand access to our products and employ a diverse workforce that values collaboration.
| Website | http://www.msd-belgium.be |
| Revenue | $30.6 million |
| Employees | 222 (174 on RocketReach) |
| Fax | +30 21 0989 7444 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+38 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Human Health, Healthcare, Animal Health, Vaccines, Health solutions, Oncology, Acute Care, Hospital Care, Diabetes |
| Web Rank | 6 Million |
| Keywords | Pharmaceutical, Healthcare, Human Health, Medicine, Research, Development, Biotechnology, Drugs, Pharma, Innovation, Therapeutics, Prescription Drugs, Medical, Manufacturing, Science, Clinical Trials, Animal Health, Global Health, Biopharma |
| Competitors | Pfizer Belgium, Novartis, Roche Diagnostics Belgium, AstraZeneca, Johnson & Johnson, Bayer SA-NV, AbbVie S.A, GSK, Merck Group, Eli Lilly Benelux N.V. +43 more (view full list) |
| SIC | SIC Code 2834 Companies, SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular MSD Belgium employee's phone or email?
The MSD Belgium annual revenue was $30.6 million in 2026.
Brecht Vanneste is the Associate Vice President and Managing Director MSD Belgium and Luxembourg of MSD Belgium.
174 people are employed at MSD Belgium.
The NAICS codes for MSD Belgium are [32, 325, 32541, 3254].
The SIC codes for MSD Belgium are [2834, 28, 283].